MedTrace Logo

Echocardiography for RILI Prediction

NCT02501707 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2019-12-04

No results posted yet for this study

Summary

Severe radiation-induced lung injury (RILI) occurs in approximately 20% of the lung cancer patients, who are treated with curative chemoradiation. In this study the investigators want to evaluate the prognostic value of baseline cardiac function assessed with echocardiography for prediction of RILI.

Conditions

Sponsors & Collaborators

  • Academisch Ziekenhuis Maastricht

    collaborator OTHER

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Dirk De Ruysscher, PhD. · MAASTRO-clinic (senior researcher)

  • Bas Kietselaer, MD,Phd · AzM/MUMC (cardiologist)

  • Judith van Loon, MD,PhD · MAASTRO-clinic (radiation oncologist)

  • Philippe Lambin, Prof,MD,Phd · MAASTRO-clinic (radiation oncologist)

  • Anne-Marie Dingemans, MD, PhD · MAASTRO-clinic (pulmonogist)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-25
Primary Completion
2019-09-12
Completion
2019-09-12

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501707 on ClinicalTrials.gov